Tomasz Kosciolek Selected Research

Kdo2-lipid A

1/2021

Gut microbiome in Schizophrenia: Altered functional pathways related to immune modulation and atherosclerotic risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomasz Kosciolek Research Topics

Disease

2	Neoplasms (Cancer) 01/2020 - 01/2019
1	Substance-Related Disorders (Drug Abuse) 08/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 08/2021
1	Coronary Disease (Coronary Heart Disease) 01/2021
1	Schizophrenia (Dementia Praecox) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Atopic Dermatitis (Atopic Eczema) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Clostridium Infections 01/2019
1	Obesity 01/2019
1	Mental Disorders (Mental Disorder) 01/2019

Drug/Important Bio-Agent (IBA)

2	Biological ProductsIBA 08/2021 - 01/2019
1	Biomarkers (Surrogate Marker)IBA 08/2021
1	tertiary amine N-oxide reductase (trimethylamine N-oxide reductase)IBA 01/2021
1	Kdo2-lipid AIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	16S Ribosomal RNAIBA 01/2021
1	CytokinesIBA 01/2021
1	dupilumabIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2020
1	Nucleic AcidsIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2019

Therapy/Procedure

1	Fecal Microbiota Transplantation 01/2019
1	Therapeutics 01/2019